Critical evaluation of hormonal therapy for carcinoma of the prostate
- 1 August 2002
- journal article
- review article
- Published by Elsevier BV in Urology
- Vol. 60 (2), 201-208
- https://doi.org/10.1016/s0090-4295(02)01677-1
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Current methods of the U.S. Preventive Services Task Force: A review of the processAmerican Journal of Preventive Medicine, 2001
- Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trialsThe Lancet, 2000
- LONG-TERM OUTCOME IN PATIENTS WITH pTxN+ ADENOCARCINOMA OF PROSTATE TREATED WITH RADICAL PROSTATECTOMY AND EARLY ANDROGEN ABLATIONJournal of Urology, 1998
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBJU International, 1997
- Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patientsThe Lancet, 1995
- Hormonal Treatment at Time of Radical Retropubic Prostatectomy for Stage D1 Prostate Cancer: Results of Long-Term FollowupJournal of Urology, 1992
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaThe New England Journal of Medicine, 1989
- The Value of Testosterone Deprivation in Stage D1 Carcinoma of the ProstateJournal of Urology, 1988
- The veterans administration cooperative urological research group's studies of cancer of the prostateCancer, 1973
- Estrogen treatment for cancer of the prostate.Early results with 3 doses of diethylstilbestrol and placeboCancer, 1970